NOVO NORDISK A/S-B (NONOF:OTCMKTS)
$40.5838 0.36 (0.895%)
Analysed NOVO NORDISK A/S-B (NONOF:OTCMKTS) News Sources
Kailera nets $625M in one of biotech’s biggest-ever IPOs
16-04-2026
biopharmadive.com
Hims & Hers Spikes; Will The FDA Blow The Door Open On Peptide Compounding?
16-04-2026
yahoo.com
Novo Workforce Changes May Signal Ongoing Reset
16-04-2026
yahoo.com
Should You Forget CVS Health and Invest in a Purer Healthcare Play?
16-04-2026
fool.com
Novo Nordisk Expands Workforce After Deep Cuts
16-04-2026
yahoo.com
Hims & Hers stock extends gains as RFK Jr. signals FDA will consider looser restrictions on peptides
16-04-2026
yahoo.com
HIMS Plunges 51.2% in 6 Months: Should You Still Hold the Stock or Sell?
16-04-2026
yahoo.com
LLY Stock Down as FDA Asks for More Safety Data on Oral Obesity Pill
16-04-2026
yahoo.com
How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q1 Results?
16-04-2026
yahoo.com
Indian's Hetero targets annual sales of 1.5 million semaglutide pens in global rollout
16-04-2026
yahoo.com
What is the current price of NOVO NORDISK A/S-B (NONOF:OTCMKTS)?
The current price of NOVO NORDISK A/S-B (NONOF:OTCMKTS) is $40.5838.
NOVO NORDISK A/S-B (NONOF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of NOVO NORDISK A/S-B (NONOF:OTCMKTS) since the previous trading day is $0.36.
NOVO NORDISK A/S-B (NONOF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of NOVO NORDISK A/S-B (NONOF:OTCMKTS) since the previous trading day is 0.895%.
What is the most recent average sentiment score for NOVO NORDISK A/S-B (NONOF:OTCMKTS)?
The most recent average sentiment score for NOVO NORDISK A/S-B (NONOF:OTCMKTS) is 43 out of 100.
What is the most recent average sentiment for NOVO NORDISK A/S-B (NONOF:OTCMKTS)?
The most recent sentiment for NOVO NORDISK A/S-B (NONOF:OTCMKTS) is .
SEC-8K** Filing Available For NOVO NORDISK A/S-B (NONOF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.